Development of a storage phosphor imaging system for proton pencil beam spot profile determination.

PURPOSE: Accurate two-dimensional (2D) profile measurements at submillimeter precision are necessary for proton beam commissioning and periodic quality assurance (QA) purposes and are currently performed at our institution with a commercial scintillation detector (Lynx PT) with limited means for independent checks. The purpose of this work was to create an independent dosimetry system consisting of an in-house optical scanner and a BaFBrI:Eu2+ storage phosphor dosimeter by: (a) determining the optimal settings for the optical scanner, (b) measuring 2D proton spot profiles with the storage phosphors, and (c) comparing them to similar measurements using a commercial scintillation detector. METHODS: An in-house 2D laboratory optical scanner was constructed and spatially calibrated for accurate 2D photostimulated luminescence (PSL) dosimetry. Square 5 × 5 cm2 BaFBrI:Eu2+ dosimeter samples were uniformly irradiated with line scans performed to determine the physical and electronic scanner settings resulting in the highest signal-to-noise ratios (SNR) at a sub-millimeter spatial resolution. The resultant spatial resolution of the scanner was then quantitatively assessed by measuring (a) line pairs on a standard X-ray lead bar phantom and (b) modulation transfer functions. Following this, 2D proton spot profiles from a Mevion S250i Hyperscan proton unit were obtained at 1, 10, 20, 30, 40, and 50 monitor unit (MU) settings at maximum energy (E0  = 227.1 MeV) and compared to baseline profiles from a commercial scintillation detector, where 1 MU is calibrated to deliver 1 Gy absolute proton dose-to-water under reference conditions, that is, 41 × 41 proton spots uniformly spaced by 0.25 cm within a 10 × 10 cm2 square field size at maximum energy (227.1 MeV) in water at depth of 5 cm at isocenter. The dosimetric system's sensitivities to (a) ±1 mm positional shifts and (b) ±0.3 mm beam lateral spread changes were quantitatively evaluated through a Gaussian fitting of the crossline and inline plots of the respective artificially shifted beam profiles. RESULTS: The physical scanner settings of (a) Δτ = 27 ms time interval between data samples, (b) vx  = 1.235 cm/s scanning speed, (c) 1% laser transmission (0.02 mW power) and (d) (Δx, Δy) = (0.33, 0.50 mm) pixel sizes with electronic settings of (a) 300 microseconds time constant, (b) normal dynamic reserve, (c) 24 dB/oct low pass filter slope, and (d) 160 Hz chopping frequency resulted in the highest SNR while maintaining sub-millimeter spatial resolution. The BaFBr0.85 I0.15 :Eu2+ storage phosphor dosimeters were linear from 1 to 50 MU and their profiles did not saturate up to 150 MU. The scanner was able to detect lateral displacements of ±1 mm in both the crossline and inline directions and ±0.3 mm beam spread changes that were artificially introduced by varying the incident proton energy. Specific to our proton unit, proton energy changes of ±1 MeV can also be detected indirectly via beam spread measurements. CONCLUSION: Our combined dosimetric system including an in-house laboratory optical scanner and reusable BaFBr0.85 I0.15 :Eu2+ storage phosphors demonstrated a sufficient spatial resolution and dosimetric accuracy to support its use as an independent proton spot measurement dosimeter system. Its wide dynamic range allows for other versatile applications such as proton halo measurements.

Technical Note: Cumulative dose modeling for organ motion management in MRI-guided radiation therapy.

PURPOSE: To develop a method for continuous online dose accumulation during irradiation in MRI-guided radiation therapy (MRgRT) and to demonstrate its application in evaluating the impact of internal organ motion on cumulative dose. METHODS: An intensity-modulated radiation therapy (IMRT) treatment plan is partitioned into its unique apertures. Dose for each planned aperture is calculated using Monte Carlo dose simulation on each phase of a four-dimensional computed tomography (4D-CT) dataset. Deformable image registration is then performed both (a) between each frame of a cine-MRI acquisition obtained during treatment and a reference frame, and (b) between each volume of the 4D-CT phases and a reference phase. These registrations are used to associate each cine image with a 4D-CT phase. Additionally, for each 4D-CT phase, the deformation vector field (DVF) is used to warp the pre-calculated dose volumes per aperture onto the reference CT dataset. To estimate the dose volume delivered during each frame of the cine-MRI acquisition, we retrieve the pre-calculated warped dose volume for the delivered aperture on the associated 4D-CT phase and adjust it by a rigid translation to account for baseline drift and instances where motion on the cine image exceeds the amplitude observed between 4D-CT phases. RESULTS: The proposed dose accumulation method is retrospectively applied to a liver cancer case previously treated on an MRgRT platform. Cumulative dose estimated for free-breathing and respiration-gated delivery is compared against dose calculated on static anatomy. In this sample case, the target minimum dose and D 98 varied by as much as 5% and 7%, respectively. CONCLUSION: We demonstrate a technique suitable for continuous online dose accumulation during MRgRT. In contrast to other approaches, dose is pre-calculated per aperture and phase and then retrieved based on a mapping scheme between cine MRI and 4D-CT datasets, aiming at reducing the computational burden for potential real-time applications.

Automatic x-ray image contrast enhancement based on parameter auto-optimization.

PURPOSE: Insufficient image contrast associated with radiation therapy daily setup x-ray images could negatively affect accurate patient treatment setup. We developed a method to perform automatic and user-independent contrast enhancement on 2D kilo voltage (kV) and megavoltage (MV) x-ray images. The goal was to provide tissue contrast optimized for each treatment site in order to support accurate patient daily treatment setup and the subsequent offline review. METHODS: The proposed method processes the 2D x-ray images with an optimized image processing filter chain, which consists of a noise reduction filter and a high-pass filter followed by a contrast limited adaptive histogram equalization (CLAHE) filter. The most important innovation is to optimize the image processing parameters automatically to determine the required image contrast settings per disease site and imaging modality. Three major parameters controlling the image processing chain, i.e., the Gaussian smoothing weighting factor for the high-pass filter, the block size, and the clip limiting parameter for the CLAHE filter, were determined automatically using an interior-point constrained optimization algorithm. RESULTS: Fifty-two kV and MV x-ray images were included in this study. The results were manually evaluated and ranked with scores from 1 (worst, unacceptable) to 5 (significantly better than adequate and visually praise worthy) by physicians and physicists. The average scores for the images processed by the proposed method, the CLAHE, and the best window-level adjustment were 3.92, 2.83, and 2.27, respectively. The percentage of the processed images received a score of 5 were 48, 29, and 18%, respectively. CONCLUSION: The proposed method is able to outperform the standard image contrast adjustment procedures that are currently used in the commercial clinical systems. When the proposed method is implemented in the clinical systems as an automatic image processing filter, it could be useful for allowing quicker and potentially more accurate treatment setup and facilitating the subsequent offline review and verification.

The role of activator concentration and precipitate formation on optical and dosimetric properties of KCl:Eu(2+) storage phosphor detectors.

PURPOSE: The activator ion (Eu(2+) in KCl:Eu(2+)) plays an important role in the photostimulated luminescence (PSL) mechanism of storage phosphor radiation detectors. In order to design an accurate, effective, and robust detector, it is important to understand how the activator ion concentration affects the structure and, consequently, radiation detection properties of KCl:Eu(2+). METHODS: Potassium chloride pellets were fabricated with various amounts of europium dopant (0.01-5.0 mol.% Eu(2+)). Clinical radiation doses were given with a 6 MV linear accelerator. Radiation doses larger than 100 Gy were given with a (137)Cs irradiator. Dose response curves, radiation hardness, and temporal signal stability were measured using a laboratory PSL readout system. The crystal structure of the material was studied using x ray diffraction and luminescence spectroscopy. RESULTS: The most intense PSL signal was from samples with 1.0 mol.% Eu. However, samples with concentrations higher than 0.05 mol.% Eu exhibited significant degradation in PSL intensity for cumulated doses larger than 3000 Gy. Structural and luminescence spectroscopy showed clear evidence of precipitate phases within the KCl lattice, especially for high activator concentrations. Analysis of PL emission spectra showed that interactions between Eu-Vc dipoles and Eu-Vc trimers could explain trends in PSL sensitivity and radiation hardness observations. CONCLUSIONS: The concentration of the activator ion (Eu(2+)) significantly affects radiation detection properties of the storage phosphor KCl:Eu(2+). An activator concentration between 0.01 and 0.05 mol.% Eu in KCl:Eu(2+) storage phosphor detectors is recommended for linear dose response, good PSL sensitivity, predictable temporal stability, and high reusability for megavoltage radiation detection.

Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy.

PURPOSE: Severe artifacts in kilovoltage-CT simulation images caused by large metallic implants can significantly degrade the conspicuity and apparent CT Hounsfield number of targets and anatomic structures, jeopardize the confidence of anatomical segmentation, and introduce inaccuracies into the radiation therapy treatment planning process. This study evaluated the performance of the first commercial orthopedic metal artifact reduction function (O-MAR) for radiation therapy, and investigated its clinical applications in treatment planning. METHODS: Both phantom and clinical data were used for the evaluation. The CIRS electron density phantom with known physical (and electron) density plugs and removable titanium implants was scanned on a Philips Brilliance Big Bore 16-slice CT simulator. The CT Hounsfield numbers of density plugs on both uncorrected and O-MAR corrected images were compared. Treatment planning accuracy was evaluated by comparing simulated dose distributions computed using the true density images, uncorrected images, and O-MAR corrected images. Ten CT image sets of patients with large hip implants were processed with the O-MAR function and evaluated by two radiation oncologists using a five-point score for overall image quality, anatomical conspicuity, and CT Hounsfield number accuracy. By utilizing the same structure contours delineated from the O-MAR corrected images, clinical IMRT treatment plans for five patients were computed on the uncorrected and O-MAR corrected images, respectively, and compared. RESULTS: Results of the phantom study indicated that CT Hounsfield number accuracy and noise were improved on the O-MAR corrected images, especially for images with bilateral metal implants. The γ pass rates of the simulated dose distributions computed on the uncorrected and O-MAR corrected images referenced to those of the true densities were higher than 99.9% (even when using 1% and 3 mm distance-to-agreement criterion), suggesting that dose distributions were clinically identical. In all patient cases, radiation oncologists rated O-MAR corrected images as higher quality. Formerly obscured critical structures were able to be visualized. The overall image quality and the conspicuity in critical organs were significantly improved compared with the uncorrected images: overall quality score (1.35 vs 3.25, P = 0.0022); bladder (2.15 vs 3.7, P = 0.0023); prostate and seminal vesicles∕vagina (1.3 vs 3.275, P = 0.0020); rectum (2.8 vs 3.9, P = 0.0021). The noise levels of the selected ROIs were reduced from 93.7 to 38.2 HU. On most cases (8∕10), the average CT Hounsfield numbers of the prostate∕vagina on the O-MAR corrected images were closer to the referenced value (41.2 HU, an average measured from patients without metal implants) than those on the uncorrected images. High γ pass rates of the five IMRT dose distribution pairs indicated that the dose distributions were not significantly affected by the CT image improvements. CONCLUSIONS: Overall, this study indicated that the O-MAR function can remarkably reduce metal artifacts and improve both CT Hounsfield number accuracy and target and critical structure visualization. Although there was no significant impact of the O-MAR algorithm on the calculated dose distributions, we suggest that O-MAR corrected images are more suitable for the entire treatment planning process by offering better anatomical structure visualization, improving radiation oncologists' confidence in target delineation, and by avoiding subjective density overrides of artifact regions on uncorrected images.